Antiphospholipid Antibodies and Systemic Scleroderma

Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 4

Abstract

Authors and Affiliations

Muhammed Mubarak, Hamid Nasri

Keywords

Related Articles

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia

To the Editor, The most common mechanisms for resistance in patients with chronic myeloid leukemia (CML) receiving imatinib mesylate are BCR-ABL kinase domain (KD) mutations. The mutations are stratifi ed according to i...

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Download PDF file
  • EP ID EP127194
  • DOI 10.4274/Tjh.2013.0127
  • Views 73
  • Downloads 0

How To Cite

Muhammed Mubarak, Hamid Nasri (2013). Antiphospholipid Antibodies and Systemic Scleroderma. Turkish Journal of Hematology, 30(4), 429-430. https://europub.co.uk/articles/-A-127194